Apoptosis-resistance of hypoxic cells: Multiple factors involved and a role for IAP-2

American Journal of Pathology

Volumn 163, Issue 2, 2003, Pages 663-671

  Dong, Zheng ^a   Wang, Jin Zhao ^a   Yu, Fushin ^a   Venkatachalam, Manjeri A ^b  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b Mays Cancer Center at UT Health San Antonio   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE; CYTOCHROME C; GLUCOSE; INHIBITOR OF APOPTOSIS PROTEIN; INHIBITOR OF APOPTOSIS PROTEIN 2; PROTEIN BAX; STAUROSPORINE; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL HYPOXIA; CELL ORGANELLE; CONTROLLED STUDY; CYTOSOL; ENZYME ACTIVATION; MITOCHONDRION; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN SECRETION; RAT;

EID: 0042845994     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)63693-0     Document Type: Article

References (42)

1. Semenza GL, Agani F, Feldser D, Iyer N, Kotch L, Laughner E, Yu A: Hypoxia, HIF-1, and the pathophysiology of common human diseases. Adv Exp Med Biol 2000, 475:123-130
2. Saikumar P, Dong Z, Weinberg JM, Venkatachalam MA: Mechanisms of cell death in hypoxia/reoxygenation injury. Oncogene 1998, 17:3341-3349
3. Cotran RS, Kumar V, Collins T: Cell injury and cellular death. Robbins Pathologic Basis of Disease. 6th ed. Edited by RS Cotran, V Kumar, T Collins. Philadelphia, W. B. Saunders Co., 1999, pp 1-29
4. Semenza GL: HIF-1 and tumor progression: pathophysiology and therapeutics. Trends Mol Med 2002, 8:S62-S67
5. Brown JM: The hypoxic cell: a target for selective cancer therapy: eighteenth Bruce F. Cain Memorial Award lecture. Cancer Res 1999, 59:5863-5870
6. Harris AL: Hypoxia: a key regulatory factor in tumour growth. Nat Rev Cancer 2002, 2:38-47
7. Bunn HF, Poyton RO: Oxygen sensing and molecular adaptation to hypoxia. Physiol Rev 1996, 76:839-885
8. Hochachka PW, Buck LT, Doll CJ, Land SC: Unifying theory of hypoxia tolerance: molecular/metabolic defense and rescue mechanisms for surviving oxygen lack. Proc Natl Acad Sci USA 1996, 93:9493-9498
9. Lopez-Barneo J, Pardal R, Ortega-Saenz P: Cellular mechanism of oxygen sensing. Annu Rev Physiol 2001, 63:259-287
10. Semenza GL: Regulation of mammalian O2 homeostasis by hypoxia-inducible factor 1. Annu Rev Cell Dev Biol 1999, 15:551-578
11. Alvarez-Tejado M, Naranjo-Suarez S, Jimenez C, Carrera AC, Landazuri MO, del Peso L: Hypoxia induces the activation of the phosphatidylinositol 3-kinase/Akt cell survival pathway in PC12 cells: protective role in apoptosis. J Biol Chem 2001, 276:22368-22374
12. Dong Z, Venkatachalam MA, Wang J, Patel Y, Saikumar P, Semenza GL, Force T, Nishiyama J: Up-regulation of apoptosis inhibitory protein IAP-2 by hypoxia: Hif-1-independent mechanisms. J Biol Chem 2001, 276:18702-18709
13. Dong Z, Nishiyama J, Yi X, Venkatachalam MA, Denton M, Gu S, Li S, Qiang M: Gene promoter of apoptosis inhibitory protein IAP2: identification of enhancer elements and activation by severe hypoxia. Biochem J 2002, 364:413-421
14. Salvesen GS, Duckett CS: IAP proteins: blocking the road to death's door. Nat Rev Mol Cell Biol 2002, 3:401-410
15. LaCasse EC, Baird S, Korneluk RG, MacKenzie AE: The inhibitors of apoptosis (IAPs) and their emerging role in cancer. Oncogene 1998, 17:3247-3259
16. Deveraux QL, Reed JC: IAP family proteins: suppressors of apoptosis. Genes Dev 1999, 13:239-252
17. Saikumar P, Dong Z, Patel Y, Hall K, Hopfer U, Weinberg JM, Venkatachalam MA: Role of hypoxia-induced Bax translocation and cytochrome c release in reoxygenation injury. Oncogene 1998, 17:3401-3415
18. Dong Z, Saikumar P, Patel Y, Weinberg JM, Venkatachalam MA: Serine protease inhibitors suppress cytochrome c-mediated caspase-9 activation and apoptosis during hypoxia-reoxygenation. Biochem J 2000, 347:669-677
19. Waterhouse NJ, Goldstein JC, von Ahsen O, Schuler M, Newmeyer DD, Green DR: Cytochrome c maintains mitochondrial transmembrane potential and ATP generation after outer mitochondrial membrane permeabilization during the apoptotic process. J Cell Biol 2001, 153:319-328
20. Gottlieb RA, Granville DJ: Analyzing mitochondrial changes during apoptosis. Methods 2002, 26:341-347
21. Mikhailov V, Mikhailova M, Pulkrabek DJ, Dong Z, Venkatachalam MA, Saikumar P: Bcl-2 prevents Bax oligomerization in the mitochondrial outer membrane. J Biol Chem 2001, 276:18361-18374
22. Dong Z, Venkatachalam MA, Weinberg JM, Saikumar P, Patel Y: Protection of ATP-depleted cells by impermeant strychnine derivatives: implications for glycine cytoprotection. Am J Pathol 2001, 158:1021-1028
23. Earnshaw WC, Martins LM, Kaufmann SH: Mammalian caspases: structure, activation, substrates, and functions during apoptosis. Annu Rev Biochem 1999, 68:383-424
24. Adams JM, Cory S: The Bcl-2 protein family: arbiters of cell survival. Science 1998, 281:1322-1326
25. Budihardjo I, Oliver H, Lutter M, Luo X, Wang X: Biochemical pathways of caspase activation during apoptosis. Annu Rev Cell Dev Biol 1999, 15:269-290
26. Green DR: Apoptotic pathways: the roads to ruin. Cell 1998, 94:695-698
27. Gross A, McDonnell JM, Korsmeyer SJ: BCL-2 family members and the mitochondria in apoptosis. Genes Dev 1999, 13:1899-1911
28. Martinou JC, Green DR: Breaking the mitochondrial barrier. Nat Rev Mol Cell Biol 2001, 2:63-67
29. Woost PG, Orosz DE, Jin W, Frisa PS, Jacobberger JW, Douglas JG, Hopfer U: Immortalization and characterization of proximal tubule cells derived from kidneys of spontaneously hypertensive and normotensive rats. Kidney Int 1996, 50:125-134
30. Antonsson B, Montessuit S, Sanchez B, Martinou JC: Bax is present as a high molecular weight oligomer/complex in the mitochondrial membrane of apoptotic cells. J Biol Chem 2001, 276:11615-11623
31. Wei MC, Zong WX, Cheng EH, Lindsten T, Panoutsakopoulou V, Ross AJ, Roth KA, MacGregor GR, Thompson CB, Korsmeyer SJ: Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science 2001, 292:727-730
32. Cheng EH, Wei MC, Weiler S, Flavell RA, Mak TW, Lindsten T, Korsmeyer SJ: BCL-2, BCL-X(L) sequester BH3 domain-only molecules preventing BAX- and BAK-mediated mitochondrial apoptosis. Mol Cell 2001, 8:705-711
33. Kuwana T, Mackey MR, Perkins G, Ellisman MH, Latterich M, Schneiter R, Green DR, Newmeyer DD: Bid, Bax, and lipids cooperate to form supramolecular openings in the outer mitochondrial membrane. Cell 2002, 111:331-342
34. Goping IS, Gross A, Lavoie JN, Nguyen M, Jemmerson R, Roth K, Korsmeyer SJ, Shore GC: Regulated targeting of BAX to mitochondria. J Cell Biol 1998, 143:207-215
35. Nomura M, Shimizu S, Sugiyama T, Narita M, Ito T, Matsuda H, Tsujimoto Y: 14-3-3 interacts directly with and negatively regulates pro-apoptotic Bax. J Biol Chem 2003, 278:2058-2065
36. Chen XQ, Yu AC: The association of 14-3-3γ and actin plays a role in cell division and apoptosis in astrocytes. Biochem Biophys Res Commun 2002, 296:657-663
37. Khaled AR, Kim K, Hofmeister R, Muegge K, Durum SK: Withdrawal of IL-7 induces Bax translocation from cytosol to mitochondria through a rise in intracellular pH. Proc Natl Acad Sci USA 1999, 96:14476-14481
38. Tafani M, Cohn JA, Karpinich NO, Rothman RJ, Russo MA, Farber JL: Regulation of intracellular pH mediates bax activation in HeLa cells treated with staurosporine or TNF-α. J Biol Chem 2002
39. Kubasiak LA, Hernandez OM, Bishopric NH, Webster KA: Hypoxia and acidosis activate cardiac myocyte death through the Bcl-2 family protein BNIP3. Proc Natl Acad Sci USA 2002, 99:12825-12830
40. Datta SR, Dudek H, Tao X, Masters S, Fu H, Gotoh Y, Greenberg ME: Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 1997, 91:231-241
41. del Peso L, Gonzalez-Garcia M, Page C, Herrera R, Nunez G: Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt. Science 1997, 278:687-689
42. Bonventre JV: Kidney ischemic preconditioning. Curr Opin Nephrol Hypertens 2002, 11:43-48